Ritlecitinib Efficacy in Adolescents With Alopecia Areata: A Real‐World Experience
Abstract
A.B. has served as consultant and/or has received fees from: Abbvie, Almirall, Amgen, BI, BMS, Eli-Lilly, Janssen, Incyte, LeoPharma, Novartis, Pfizer, Sanofi, and UCB. E.F. has served as consultant and/or has received fees from: Abbvie, Incyte, Lilly, Oreal, Pierre Fabre, Pfizer, Sanofi, and Shiseido. The data that support the findings of this study are available from the corresponding author upon reasonable request.
Fields of Study & Subjects
Hair Growth and Disorders
Skin and Cellular Biology Research
Neurological diseases and metabolism
Publication details
- Journal / source
- International Journal of Dermatology
- Publisher
- Wiley
- Volume
- 65
- Issue
- 9
- Pages
- 1932–1934
- Publication date
- 11 February 2026
- Language
- EN